US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
Revolution Medicines Inc RVMD
$145.66
▼ -2.55%
($-3.81)
Open
$147.84
Prev Close
$149.47
Day Range
$141.25 – $148.86
52W Range
$34.00 – $155.70
Market Cap
$30.60B
Beta
1.40
EPS (TTM)
$-4.80
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-02-13 |
| Shares Out. | 198,170,000 |
| Website | revmed.com/ ↗ |
| Phone | 13026365400 |
Revolution Medicines Inc is a publicly traded company under the ticker symbol RVMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
27 analysts (2026-05-01)
📰 Latest News for RVMD
Erasca: 'Hold' On Substantial RAS Targeting ERAS-0015 But With Two Key Risks
$100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today
RBC Capital Maintains Outperform on Revolution Medicines, Raises Price Target to $165
Wedbush Maintains Outperform on Revolution Medicines, Raises Price Target to $165
Piper Sandler Maintains Overweight on Revolution Medicines, Raises Price Target to $172
Needham Maintains Buy on Revolution Medicines, Lowers Price Target to $183
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call Transcript